In a new report by the World Health Organization (WHO), the specialized agency of the United Nations has officially given the approval to cannabidiol, a.k.a. CBD, a relaxing compound in medical marijuana, ruling it is not a dangerous drug, despite U.S. federal policy.
While the ruling indicates that it should not be a scheduled drug, meaning that it is not a drug that has a high potential for abuse or is illegal to manufacture or distribute, the WHO Expert Committee on Drug Dependence announced, “Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions.”
In addition, the WHO team determined there’s “preliminary evidence” that CBD could be useful in treating Alzheimer’s disease, cancer, psychosis, Parkinson’s disease and other serious conditions, while also declaring that taking medical marijuana will not lead to addiction to THC, the psychoactive property of cannabis that induces a “high” feeling, according to the preliminary report.
With the FDA still iffy on updating its position on cannabis products despite an ever-growing positive evidence on the subject, it will be one of a number of agencies that will be advising the WHO in its final review of cannabis and cannabis related substances, which is set to be published in May 2018.
Stay tuned for more updates.
- Source: Dailymail
- Main / Featured Image: David McNew / Getty